Urinary Incontinence Market Research
Urinary Incontinence is loss of bladder control and is a rather common condition than may be realized. Urinary incontinence often takes over the patient’s life limiting social activity and even work. The treatment for this condition depends on the type of problem you have and what best fits your lifestyle. It may include simple exercises, medicines, special devices or procedures prescribed by your doctor, or surgery.
Research indicates that the global Urinary Incontinence (UI) therapeutics market was worth approximately $2.5 billion in 2009. Further, the global UI therapeutics market is expected to reach $3.4 billion by 2017 after growing at a CAGR of 3.5%.
The Urinary Incontinence drug therapy market research report provides insight into the pipeline status of urinary incontinence therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.
The study basically aims at providing a comprehensive overview of the on-goings of the urinary incontinence drugs & therapy market.